Osteopore Ltd has released a press release.
Osteopore secures EU market approvals for custom implants
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Osteopore
- Reinstatement to Quotation
- Suspension from Quotation
- Convertible Note Prospectus
- Drawdown of Tranche 1 of the Redeemable Convertible Notes
- Activities Report December 2024 and Appendix 4C
Later from Osteopore
- Activities Report March 2025 and Appendix 4C
- Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership
- Osteopore Limited (ASX: OSX) Elevates Partnership with Kelyniam for the U.S. Craniofacial Market
- Osteopore gains access to Switzerland
- Business progress update, Zimmer Biomet sales units grows 3x
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore